About PRAHA VACCINES
PRAHA VACCINES is a company based in Kutna Hora (Czechia) founded in 2017 was acquired by Novavax in May 2020. The company has 4,148 employees as of December 31, 2021. PRAHA VACCINES operates in a competitive market with competitors including Neovacs, Intravacc, Fina Biosolutions, Yapanbio and VERAXA, among others.
- Headquarter Kutna Hora, Czechia
- Employees 4148 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Active 24, S.R.O.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PRAHA VACCINES
Detailed funding history for PRAHA VACCINES
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in PRAHA VACCINES
PRAHA VACCINES has secured backing from 1 investor. Prominent investors backing the company include Novavax.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Novel vaccines are developed using nanoparticle and matrix adjuvant technology.
|
Locked | Locked | Locked |
Investor details for PRAHA VACCINES
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PRAHA VACCINES
Investment portfolio details for PRAHA VACCINES
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PRAHA VACCINES
Detailed financials for PRAHA VACCINES
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Praha Vaccines Comparisons
Peer comparison for PRAHA VACCINES
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PRAHA VACCINES
PRAHA VACCINES operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Intravacc, Fina Biosolutions, Yapanbio and VERAXA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccine manufacturing services are provided by Neovacs CDMO.
|
|
| Locked | Locked | Locked |
Vaccine development services for bacterial and viral vaccines are provided.
|
|
| Locked | Locked | Locked |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| Locked | Locked | Locked |
Contract manufacturing of bio-therapeutics and vaccines is provided.
|
|
| Locked | Locked | Locked |
Antibody therapeutics for cancer treatment are developed via microfluidic screening.
|
|
| Locked | Locked | Locked |
New molecules are discovered, developed, and manufactured in biotechnology.
|
Detailed competitors of PRAHA VACCINES
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Praha Vaccines
Complete news archive for PRAHA VACCINES
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PRAHA VACCINES
PRAHA VACCINES was founded in 2017.
PRAHA VACCINES is headquartered in Kutna Hora, Czechia. It is registered at Kutna Hora, Central Bohemian Region, Czechia.
As of Dec 31, 2021, the latest employee count at PRAHA VACCINES is 4,148.
Annual revenue of PRAHA VACCINES is $8.29M as on Dec 31, 2022.
PRAHA VACCINES was established in 2017 in Kutna Hora, Czech Republic. Operations are centered on the development and production of serums and vaccines within the biotechnology and pharmaceutical sectors. Research activities are conducted to support vaccine manufacturing, with a focus on serum-based solutions. The companys domain, prahavaccines.cz, facilitates information dissemination. Geographic operations remain based in the Czech Republic, serving regional and potential international needs.
PRAHA VACCINES has 1 investor. Key investors include Novavax.